v3.24.3

Significant Transactions (Tables) - RubrYc Therapeutics

12 Months Ended

Jun. 30, 2024

Asset Purchase Agreement

Summary of Purchase Price Allocation of Asset Acquisition

​

​	​	​	​
Intangible assets	​	$	1,228,000
Fixed assets	​	​	114,000
​	​	$	1,342,000

Stock Purchase Agreement

Summary of Purchase Price Allocation of Asset Acquisition

The Company accounted for the agreements as an asset purchase and allocated the purchase price of $7,500,000 as follows:

​

​	​	​	​
Preferred stock	​	$	1,760,000
Intangible assets	​	​	4,300,000
Prepaid expenses	​	​	1,440,000
​	​	$	7,500,000

X

- Definition

Tabular disclosure of asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 50
-Name Accounting Standards Codification
-Section 15
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480123/805-50-15-3

+ Details

Name:	us-gaap_AssetAcquisitionTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_CounterpartyNameAxis=ibio_RubrycTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AssetAcquisitionAxis=ibio_AssetPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=ibio_StockPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: